Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1379/week)
    • Manufacturing(708/week)
    • Energy(572/week)
    • Technology(1289/week)
    • Other Manufacturing(492/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Oncolytics Biotech® Inc.

Jul 29, 2025
Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End
Jul 23, 2025
Key Opinion Leader Event Highlights Pelareorep's Compelling Pancreatic and Gastrointestinal Data And Future Potential
Jul 22, 2025
Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules
Jul 08, 2025
Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies
Jun 11, 2025
Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
May 23, 2025
Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities
May 14, 2025
Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum
May 06, 2025
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
Apr 24, 2025
Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action
Apr 10, 2025
Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital
Apr 10, 2025
Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers
Mar 07, 2025
Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024
Feb 25, 2025
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
Feb 18, 2025
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
Feb 07, 2025
Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence
Jan 22, 2025
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
Jan 15, 2025
Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
Dec 23, 2024
Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data
Dec 18, 2024
Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium
Oct 04, 2024
Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path
  •  
  • Page 1
  • ››

Latest News

Aug 5, 2025

Eku Energy’s battery storage projects in Essex and Buckinghamshire are commissioned with BESS supplier NHOA...

Aug 5, 2025

Mission Success for Rocket Lab’s Latest Constellation Deployment Launch for iQPS

Aug 5, 2025

American Water Announces Pricing of Common Stock Offering of 7,042,254 Shares with a Forward Component

Aug 5, 2025

Toshiba Releases Lens-Reduction Type CCD Linear Image Sensor with Low Random Noise That Helps Improve Image...

Aug 5, 2025

Jeh Aerospace Secures $11 Million from Elevation Capital, General Catalyst to Scale Next-Generation Aerospace...

Aug 5, 2025

Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy

Aug 5, 2025

Otter Tail Corporation Announces Second Quarter Earnings and Increases Annual Earnings Guidance

Aug 5, 2025

Geospace Technologies Acquires National Lab Developed Heartbeat Detector Technology

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia